Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

401 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcomes of a nine-month regimen for rifampicin-resistant tuberculosis up to 24 months after treatment completion in nine African countries.
Schwœbel V, Trébucq A, Kashongwe Z, Bakayoko AS, Kuaban C, Noeske J, Harouna SH, Souleymane MB, Piubello A, Ciza F, Fikouma V, Gasana M, Ouedraogo M, Gninafon M, Van Deun A, Tagliani E, Cirillo DM, Koura KG, Rieder HL. Schwœbel V, et al. Among authors: cirillo dm. EClinicalMedicine. 2020 Feb 10;20:100268. doi: 10.1016/j.eclinm.2020.100268. eCollection 2020 Mar. EClinicalMedicine. 2020. PMID: 32300732 Free PMC article.
Extensively drug-resistant tuberculosis, Burkina Faso.
Saleri N, Badoum G, Ouedraogo M, Dembele SM, Nacanabo R, Bonkoungou V, Cirillo D, Pinsi G, Matteelli A. Saleri N, et al. Emerg Infect Dis. 2010 May;16(5):840-2. doi: 10.3201/eid1605.091262. Emerg Infect Dis. 2010. PMID: 20409379 Free PMC article.
Diagnostic Performance of the New Version (v2.0) of GenoType MTBDRsl Assay for Detection of Resistance to Fluoroquinolones and Second-Line Injectable Drugs: a Multicenter Study.
Tagliani E, Cabibbe AM, Miotto P, Borroni E, Toro JC, Mansjö M, Hoffner S, Hillemann D, Zalutskaya A, Skrahina A, Cirillo DM. Tagliani E, et al. Among authors: cirillo dm. J Clin Microbiol. 2015 Sep;53(9):2961-9. doi: 10.1128/JCM.01257-15. Epub 2015 Jul 15. J Clin Microbiol. 2015. PMID: 26179309 Free PMC article.
Reaching consensus on drug resistance conferring mutations.
Cirillo DM, Miotto P, Tagliani E; ReSeqTB Consortium. Cirillo DM, et al. Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S31-S32. doi: 10.1016/j.ijmyco.2016.09.062. Epub 2016 Nov 15. Int J Mycobacteriol. 2016. PMID: 28043595 Free article.
Reaching consensus on drug resistance conferring mutations.
Cirillo DM, Miotto P, Tagliani E; ReSeqTB Consortium. Cirillo DM, et al. Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S33. doi: 10.1016/j.ijmyco.2016.11.009. Epub 2016 Nov 25. Int J Mycobacteriol. 2016. PMID: 28043596 Free article. No abstract available.
Treatment outcome with a short multidrug-resistant tuberculosis regimen in nine African countries.
Trébucq A, Schwoebel V, Kashongwe Z, Bakayoko A, Kuaban C, Noeske J, Hassane S, Souleymane B, Piubello A, Ciza F, Fikouma V, Gasana M, Ouedraogo M, Gninafon M, Van Deun A, Cirillo DM, Koura KG, Rieder HL. Trébucq A, et al. Among authors: cirillo dm. Int J Tuberc Lung Dis. 2018 Jan 1;22(1):17-25. doi: 10.5588/ijtld.17.0498. Epub 2017 Nov 17. Int J Tuberc Lung Dis. 2018. PMID: 29149917
401 results